Medical Device Investing Adherium Launches Hailie Solution Direct-to-Consumer in the U.S. for Better Asthma and COPD Management
Adherium Receives Additional U.S. FDA 510(k) Clearance for U.S. Consumer Launch of the Hailieâ„¢ Solution
Juggernaut Announces Strategic Investment by Crescat Capital Funds for 28.95% Ownership - Dr. Quinton Hennigh Technical Advisor